QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wall-street-rallies-after-last-weeks-sell-off-palantir-soars-on-sp-500-inclusion-airlines-rally-whats-driving-markets-monday

U.S. stocks started the new week with strong gains, as all major indices and sectors in the S&P 500 were in the green by mi...

 why-is-moderna-stock-trading-higher-on-monday

Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vac...

 modernas-quebec-facility-gains-health-canada-approval-set-to-produce-mrna-vaccines-domestically

Moderna, Inc. (NASDAQ:MRNA) today announced that its manufacturing facility in Laval, Quebec, has been granted a Drug Establish...

 intel-moderna-and-dollar-general-were-among-top-10-large-cap-losers-in-august-are-the-others-in-your-portfolio

10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fie...

Core News & Articles

 - Reuters

Core News & Articles

https://www.nbcnews.com/health/health-news/us-prepares-possible-arrival-severe-strain-mpox-rcna169926 Senior Biden administrati...

 modernas-investigational-mpox-vaccine-more-effective-than-current-approved-shot-animal-study-shows

Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperfo...

Core News & Articles

https://ec.europa.eu/commission/presscorner/detail/en/ip_24_4523 Today, close to 100,000 mpox vaccine doses will arrive in the ...

 jim-cramer-oklo-is-losing-money-hand-over-fist-but-this-private-equity-stock-is-a-buy

The "Mad Money" host said Oklo Inc. is a company that is again losing so much money "I can't even look at it."

 modernas-updated-covid-19-vaccine-targeting-sars-cov-2-variant-jn1-receives-authorization-recommendation-from-ema-committee

- Reuters 

 moderna-reports-encouraging-results-on-its-mpox-vaccine-as-outbreaks-in-africa-spread---stat-news

https://www.statnews.com/2024/09/04/moderna-mpox-vaccine-study-results/

 uk-taiwan-approve-modernas-updated-covid-19-shot

The Medicines and Healthcare Products Regulatory Agency has approved Moderna's updated COVID-19 vaccine targeting the JN.1 ...

 uks-mhra-approves-an-adapted-spikevax-moderna-covid-19-vaccine-that-targets-the-jn1-covid-19-subvariant

-Reuters

 reported-earlier-modernas-new-covid-vaccine-approved-in-taiwan-for-kids-and-adults

Moderna, Inc. (NASDAQ:MRNA) today announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formul...

 magnificent-7-miss-out-2-cybersecurity-stocks-stand-firm-retailers-lag-in-volatile-august-here-are-the-top-sp-500-gainers-and-losers

The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION